We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Genetic Predisposition and AIDS

By Biotechdaily staff writers
Posted on 25 Jan 2005
Researchers studying the relationship between genetic predisposition and infectious diseases have linked two specific genes to higher and lower levels of susceptibility to HIV/AIDS.

Investigators at the University of Texas Health Science Center (San Antonio, USA) and the Wilford Hall Medical Center (Lackland Air Force Base, TX, USA) analyzed more than 4,300 blood samples from individuals, both HIV-positive and -negative, from various ethnic origins to determine the number of copies of CCL3L1, a gene that encodes a potent HIV-blocking protein, carried by each person.

They reported in the January 6, 2005, online issue of Science Express, that among the healthy group, African-American adults had an average of four CCL3L1 copies, while European and Hispanic-American adults averaged two and three copies, respectively. More...
When HIV-positive individuals possessed fewer than the average number of copies for their ethnic type, they had a 39-260% higher risk of rapid progression to AIDS than did those with the average number of copies. An above-average number of copies provided additional protection against progressing to active AIDS. Each additional CCL3L1 copy lowered the risk 4.5-10.5%, depending on ethnic background.

The protective effect of the CCL3L1 protein was linked to its interaction with CCR5, a major HIV-receptor protein. Individuals who possessed a lower-than-average number of CCL3L1 copies as will as certain CCR5 variants had a substantially higher risk of HIV acquisition and rate of progression to AIDS.

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Electrolyte Analyzer
BKE-B
New
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.